Acadia Pharmaceuticals Inc
ACAD - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.24B
Close$
$-9.73
151.9% downside
Current Fair Value
151.9% downsideOvervalued by 151.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.24 Billion |
|---|---|
| Enterprise Value | $2.99 Billion |
| Earnings per Share | $2.32 |
| Beta | 0.89 |
| Outstanding Shares | 172,545,000 |
Return
| Return on Equity | 26.11% |
|---|---|
| Return on Assets | 20.19% |
| Return on Invested Capital | 8.98% |
Valuation & Multiples
| P/E Ratio | 8.8 |
|---|---|
| PEG | -34.61 |
| Price to Sales | 3.13 |
| Price to Book Ratio | 2.34 |
| Enterprise Value to Revenue | 2.49 |
| Enterprise Value to EBIT | 22.77 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 4, 2026
EPS
$0.31
Est. $0.20Revenue
$342.29 M
Est. $332.58 MNext Earnings Call
Expected Date
February 24, 2027
EPS Estimate
$0.28
Consensus analyst estimateRevenue Estimate
$362.59 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.68, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.6833▼ 31.76% |
|---|---|
| Total Calls | 371,600▲ 51.00% |
| Total Puts | 253,900▲ 3.09% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 50.23%▼ 48.78% |
|---|---|
| Total Invested | $1.74B▼ 59.59% |
| Investors Holding | 268▼ 97.00% |
About Acadia Pharmaceuticals Inc
CEO: Uli Hacksell
